Ropivacaine mesylate
目录号: PL09484 纯度: ≥98.0%
CAS No. :854056-07-8
商品编号 规格 价格 会员价 是否有货 数量
PL09484-10mg 10mg ¥556.36 请登录
PL09484-50mg 50mg ¥1001.45 请登录
PL09484-100mg 100mg 询价 询价
PL09484-200mg 200mg 询价 询价
PL09484-10mM*1mLinWater 10mM*1mLinWater ¥680.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Ropivacaine mesylate
中文别名
甲磺酸罗哌卡因;N-(2,6-二甲基苯基)-1-丙基哌啶-2-甲酰胺甲磺酸盐;R-甲磺酸罗哌卡因;s-罗哌卡因甲磺酸盐;s-罗哌卡因甲磺酸盐,s-罗哌卡因;罗哌卡因甲磺酸盐;N-(2,6-二甲基苯基)-1-正丙基哌啶-2-甲酰胺甲磺酸盐;甲磺酸罗哌卡因中间体
英文名称
Ropivacaine mesylate
英文别名
Ropivacaine mesylate;(2S)-N-(2,6-Dimethylphenyl)-1-propyl-2-piperidinecarboxamide monomethanesulfonate;Ropivacaine Mesylate API;Ropivacaine Mesilate;Ropivacaine methanesulfonate;MJO2D2C5RI;C17H26N2O.CH4O3S;EBD6814;API0007267;M57R954;M881;Q27284072
Cas No.
854056-07-8
分子式
C18H30N2O4S
分子量
370.51
包装储存
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
产品详情
Ropivacaine mesylate 是一种有效的钠通道 (sodium channel) 阻断剂。Ropivacaine 通过可逆地抑制钠离子内流 (sodium ion influx) 从而引起神经纤维脉冲传导阻滞。Ropivacaine 也是一种 K2P (双孔钾通道) TREK-1 的抑制剂,在 COS-7 细胞膜上的 IC50 值为 402.7 μM。
生物活性
Ropivacaine mesylate is a long-acting amide local anaesthetic agent for a spinal block and effectively blocks neuropathic pain. Ropivacaine blocks impulse conduction via reversible inhibition of sodium ion influx in nerve fibressup>[1]. Ropivacaine is also an inhibitor of K 2P (two-pore domain potassium channel) TREK-1 with an IC 50  of 402.7 μM in COS-7 cells membrane.
性状
Solid
IC50 & Target[1][2]
IC50: sodium ion influx
IC50: 402.7 μM (TREK-1 in COS-7 cells membrane)
体内研究(In Vivo)
Epidural administration of Ropivacaine mesylate effectively blocks neuropathic pain (both mechanical allodynia and heat hyperalgesia) without induction of analgesic tolerance and significantly delays the development of neuropathic pain produced by peripheral nerve injury.
Ropivacaine mesylate inhibits pressure-induced increases in filtration coefficient (Kf) without affecting pulmonary artery pressure (Ppa), pulmonary capillary pressures (Ppc), and zonal characteristics (ZC).
Ropivacaine mesylate prevents pressure-induced lung edema and associated hyperpermeability as evidence by maintaining PaO2, lung wet-to-dry ratio and plasma volume in levels similar to sham rats.
Ropivacaine mesylate inhibits pressure-induced NO production as evidenced by decreased lung nitro-tyrosine content when compared to hypertensive lungs.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
ClinicalTrial
参考文献
[1]. Li TF, et al. Epidural sustained release ropivacaine prolongs anti-allodynia and anti-hyperalgesia in developing and established neuropathic pain. PLoS One. 2015 Jan 24;10(1):e0117321.
[2]. Milan Patel, et al. Ropivacaine Inhibits Pressure-Induced Lung Endothelial Hyperpermeability in Models of Acute Hypertension. Life Sci. 2019 Apr 1;222:22-28.
溶解度数据
In Vitro: H2O : 250 mg/mL (674.75 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

相关产品

更多
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2